Learn More
Invitrogen™ SARS-CoV-2 Spike Protein S1/S2 (B.1.1.7) His-tag, trimer Recombinant Protein

Description
It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (400 μL) be added to the vial to prepare a stock solution of 0.25 mg/mL. Concentration is measured by UV. SARS-CoV-2 spike S1/S2 (Accession # YP_009724390.1) with (69-70, 145) deletions and N501Y, A570D, D614G, T716I, F817P, A892P, A899P, A942P, S982A, K986P, V987P, D1118H substitutions and furin cleavage site mutations expressed with the bacteriophage T4 fibritin and a C-terminal His-tag. The mutations were identified in the SARS-CoV-2 varient known as B.1.1.7.

Specifications
Specifications
For Use With (Application) | ELISA |
Format | Lyophilized |
Formulation | PBS with 0.01% mannitol, 0.01% Tween 80, 5-8% trehalose and no preservative; pH 7.4 |
Molecular Weight (g/mol) | 136.18 kDa |
Name | SARS-CoV-2 Spike Protein S1/S2 (B0.1.1.7) His-tag, trimer |
Purification Method | SDS-PAGE |
Quantity | 100 μg |
Regulatory Status | RUO |
Endotoxin Concentration | <1.0 EU/μg |
Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV-2 |
Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.